Headway
Headway raises $125M Series C at $3.2B valuation
Quick Facts
Headway: Series C Funding Round
Headway has successfully raised $125M in Series C funding, reaching a valuation of $3.2B.
Company Overview
Mental health care platform
Funding Details
The Series C round was led by Accel, with participation from Andreessen Horowitz, GV, Spark Capital, Thrive Capital.
Company Information
- Headquarters: 568 Broadway, New York, NY 10012
- Founded: 2019
- Employees: 400+
- Category: HealthTech
Investment
Headway plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Accel: Verified investor in Series C
- Andreessen Horowitz: Verified investor in Series C
- GV: Verified investor in Series C
- Spark Capital: Verified investor in Series C
- Thrive Capital: Verified investor in Series C
Key Investors
About the Author
Related Company Reports
Abridge Raises $150M Series C to Transform HealthTech
Abridge has secured $150M Series C in funding to accelerate growth and innovation in the healthtech sector. Medical AI scribe platform automatically documenting patient-provider conversations and generating clinical notes...
Innovaccer Raises $275M Series F to Transform HealthTech
Innovaccer has secured $275M Series F in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform unifying patient data and providing analytics for value-based care and population health manage...
Truveta Raises $95M Series B to Transform HealthTech
Truveta has secured $95M Series B in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform aggregating de-identified patient records to accelerate medical research and drug development...
